世界の創薬アウトソーシング市場の規模は2021年に33億ドルに達し、予測期間中のCAGRは7.4％と予想されます。米国、ヨーロッパ、中国の120人の臨床開発意思決定者のライフサイエンス戦略グループが実施した調査によると、業界の専門家は、COVID-19パンデミック後の予測不可能な市場シナリオでシェアを維持するために大きな戦略的変更に取り組んでいます。製薬業界は、生物学的製剤への移行、特許の失効、大型医薬品の自社発見という前例のない縮小という点で、過去20年間に急速な変化を遂げてきました。これらの全てが、アウトソーシング活動の取組みを加速させています。
ヒット確認、リード生成、リード最適化、高速スクリーニングなど、創薬のさまざまな段階を分析することによって、プレーヤーはコアサービスに特化することができます。バイオ医薬品業界の研究開発費の推定75.0％から80.0％を外部委託することによって、受託研究機関（CRO）のビジネスチャンスを創出し、それが市場の成長を後押しすることが期待されます。製薬会社は、熟練した人材、低コスト、高品質のデータに裏打ちされた発展途上国の製造施設と提携しています。コスト削減、イノベーションの追求、専門知識や技術の入手、スピードと敏捷性の向上が、製薬会社がアウトソーシングレベルの拡大を促進する重要な要因です。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Workflow
1.1.2. Therapeutics Area
1.1.3. Drug Type
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
1.9.3. Objective 3:
1.9.4. Objective 4:
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Industry challenges
3.4. Drug Discovery Outsourcing Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Definitions and Scope
4.3. Drug Discovery Outsourcing Market Share, 2021 & 2030
4.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.4.1. Target Identification & Screening
4.4.2. Target Validation & Functional Informatics
4.4.3. Lead Identification & Candidate Optimization
4.4.4. Preclinical Development
4.4.5. Other Associated Workflow
Chapter 5. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Definitions and Scope
5.3. Drug Discovery Outsourcing Market Share, 2021 & 2030
5.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.4.1. Respiratory System
5.4.2. Pain and Anesthesia
5.4.3. Oncology
5.4.4. Ophthalmology
5.4.5. Hematology
5.4.6. Cardiovascular
5.4.7. Endocrine
5.4.8. Gastrointestinal
5.4.9. Immunomodulation
5.4.10. Anti-Infective
5.4.11. Central Nervous System
5.4.12. Dermatology
5.4.13. Genitourinary System
Chapter 6. Drug Discovery Outsourcing Market: Drug Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Definitions and Scope
6.3. Drug Discovery Outsourcing Market Share, 2021 & 2030
6.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.4.1. Small Molecules
6.4.2. Large Molecules (Biopharmaceuticals)
Chapter 7. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2021 & 2030
7.3. Regional Market Share, 2020
7.4. North America
7.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.5. Europe
7.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.5.2. U.K.
7.5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.7. Latin America
7.7.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.8. MEA
7.8.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.1.1. Albany Molecular Research Inc.
8.1.1.1. Company overview
8.1.1.2. Financial performance
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. EVOTEC
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. Laboratory Corporation of America Holdings
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. GenScript
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. PPD Inc
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Charles River
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. WuXi AppTec
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. Merck & Co., Inc.
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Thermo Fisher Scientific Inc.
8.1.9.1. Company overview
8.1.9.2. Financial performance
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. Dalton Pharma Services
8.1.10.1. Company overview
8.1.10.2. Financial performance
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. Oncodesign
8.1.11.1. Company overview
8.1.11.2. Financial performance
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives
8.1.12. Jubilant Biosys
8.1.12.1. Company overview
8.1.12.2. Financial performance
8.1.12.3. Product benchmarking
8.1.12.4. Strategic initiatives
8.1.13. DiscoverX Corporation
8.1.13.1. Company overview
8.1.13.2. Financial performance
8.1.13.3. Product benchmarking
8.1.13.4. Strategic initiatives
8.1.14. QIAGEN
8.1.14.1. Company overview
8.1.14.2. Financial performance
8.1.14.3. Product benchmarking
8.1.14.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global Drug Discovery Outsourcing Market, by Region 2017 - 2030 (USD Million)
Table 4 Global Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 5 Global Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 6 Global Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 7 North America Drug Discovery Outsourcing Market, by Country, 2017 - 2030 (USD Million)
Table 8 North America Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 9 North America Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 10 North America Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 11 U.S. Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 12 U.S. Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 13 U.S. Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 14 Canada Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 15 Canada Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 16 Canada Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 17 Europe Drug Discovery Outsourcing Market, by Country, 2017 - 2030 (USD Million)
Table 18 Europe Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 19 Europe Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 20 Europe Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 21 U.K. Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 22 U.K. Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 23 U.K. Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 24 Germany Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 25 Germany Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 26 Germany Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 27 Asia Pacific Drug Discovery Outsourcing Market, by Country, 2017 - 2030 (USD Million)
Table 28 Asia Pacific Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 29 Asia Pacific Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 30 Asia Pacific Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 31 Japan Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 32 Japan Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 33 Japan Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 34 China Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 35 China Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 36 China Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 37 Latin America Drug Discovery Outsourcing Market, by Country, 2017 - 2030 (USD Million)
Table 38 Latin America Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 39 Latin America Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 40 Latin America Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 41 Brazil Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 42 Brazil Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 43 Brazil Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 44 MEA Drug Discovery Outsourcing Market, by Country, 2017 - 2030 (USD Million)
Table 45 MEA Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 46 MEA Drug Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 47 MEA Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
Table 48 South Africa Drug Discovery Outsourcing Market, by Workflow, 2017 - 2030 (USD Million)
Table 49 South Africa Discovery Outsourcing Market, by Therapeutics Area, 2017 - 2030 (USD Million)
Table 50 South Africa Drug Discovery Outsourcing Market, by Drug Type, 2017 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Drug Discovery Outsourcing market: Market snapshot
Fig. 9 Drug Discovery Outsourcing market: Market segmentation
Fig. 10 Drug Discovery Outsourcing market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Drug Discovery Outsourcing market driver impact
Fig. 14 Drug Discovery Outsourcing market restraint impact
Fig. 15 Drug Discovery Outsourcing market porter’s five forces analysis
Fig. 16 Drug Discovery Outsourcing market PESTEL analysis
Fig. 17 Drug Discovery Outsourcing market segment dashboard
Fig. 18 Drug Discovery Outsourcing market: workflow movement Analysis
Fig. 19 Target identification & screening drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 20 Target validation & functional informatics drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 21 Lead identification & candidate optimization drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 22 Preclinical development drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 23 Other associated workflow drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 24 Drug Discovery Outsourcing market segment dashboard
Fig. 25 Respiratory system drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 26 Pain and anesthesia drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 27 Oncology drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 28 Ophthalmology drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 29 Hematology drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 30 Cardiovascular drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 31 Endocrine drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 32 Gastrointestinal drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 33 Immunomodulation drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 34 Anti-infective drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 35 Central nervous system drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 36 Dermatology drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 37 Dermatology drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 38 Genitourinary system drug discovery outsourcing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 39 Global drug discovery outsourcing market: Regional movement analysis
Fig. 40 Global market share, by region
Fig. 41 North America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 42 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 43 Canada market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 44 Europe market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 45 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 46 Germany market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 47 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 48 Japan market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 49 China market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 50 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 51 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 52 Middle East and Africa market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 53 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
